To demonstrate and validate a breath test for detection of early stage lung cancer that could potentially reduce number of deaths.
This is a multicenter study comparing several groups of subjects with and without lung cancer by CT scan, biopsy and the breath test. The breath test will be performed to validate the methodology and the predictive algorithm that were previously developed.
Study Type
OBSERVATIONAL
Enrollment
215
Breath collected and analyzed for markers of lung cancer.
Christiana Hospital
Newark, Delaware, United States
MD Anderson Cancer Center
Orlando, Florida, United States
New York University Medical Center
New York, New York, United States
Swedish Cancer Institute
Seattle, Washington, United States
Sensitivity and specificity of the breath test as compared to CT and pathology to support primary lung cancer diagnosis.
Time frame: 30 days after completion.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.